SCHEMBL4137378

SCHEMBL4137378

COc1cc(-n2cccc2)c(Cl)cc1C=C1SC(Nc2ccc(CC(=O)O)cc2)=NC1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 3/20 0.37
PDE4B Q07343 2/20 0.36
PDE4D Q08499 2/20 0.36
PTPN1 P18031 1/20 0.36
MEN1 O00255 5/20 0.35
KMT2A Q03164 5/20 0.35
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 2/20 0.35
MAPT P10636 2/20 0.35
GAA P10253 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
S1PR1 P21453 1/20 0.35
CISD1 Q9NZ45 1/20 0.35
TAS2R14 Q9NYV8 1/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
RECQL P46063 1/20 0.35
RAB9A P51151 1/20 0.35
POLB P06746 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4137375 1.00 ALOX5 (0.37) ALOX5PDE4BPDE4DPTPN1MEN1
SCHEMBL4138368 0.85 EGFR (0.42) ALOX5MEN1KMT2AALDH1A1KDM4E
SCHEMBL4138363 0.85 EGFR (0.42) ALOX5MEN1KMT2AALDH1A1KDM4E
SCHEMBL4122284 0.80 PDE4B (0.42) ALOX5PDE4BPDE4DALDH1A1KDM4E
SCHEMBL4122280 0.80 PDE4B (0.42) ALOX5PDE4BPDE4DALDH1A1KDM4E
SCHEMBL4634765 0.77 ALOX5 (0.52) ALOX5PDE4BPDE4DMEN1KMT2A
SCHEMBL4634758 0.77 ALOX5 (0.52) ALOX5PDE4BPDE4DMEN1KMT2A
SCHEMBL4131441 0.76 KMT2A (0.51) ALOX5MEN1KMT2AALDH1A1KDM4E
SCHEMBL4136345 0.76 KMT2A (0.51) ALOX5MEN1KMT2AALDH1A1KDM4E
SCHEMBL4127737 0.76 KMT2A (0.49) ALOX5MEN1KMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors TORRENT PHARMACEUTICALS LIMITED (IN) 2009-04-02 US claimed
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors TORRENT PHARMACEUTICALS LIMITED (IN) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors PTPRF, PTPA, PTPRJ ALOX5 3505/4885PDE4B 161/4885PDE4D 485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.